Johnson & Johnson annual net income for 2019 was $15.119B, a 1.16% decline from 2018. And those newer drugs delivered at the same time aging stalwart Remicade stubbornly clung to market share to pitch in $13 billion despite biosimilar competition. Domestic sales increased 1.5%. Reproduction in whole or part is prohibited. Johnson & Johnson’s total revenue grew from $71.8 billion in 2016 to $81.6 billion in 2018. Psoriasis and psoriatic arthritis drug Stelara ginned up $5.2 billion last year, a 28% year-over-year sales hike, and psoriasis newcomer Tremfya brought in $544 million, up from just $63 million in 2017. One could argue, however, that J&J doesn’t belong in first place in this annual ranking. Its pharma unit turned in more than half of that figure. The U.S. government will pay $31 million to Cytiva, formerly GE Life Sciences, to scale capacity for COVID-19 vaccine components across two states. A new lab network promises an answer. For all of 2018, Johnson & Johnson reported revenue of $81.58 billion, up 6.7 percent, and net income of $15.3 billion, or $5.61 per share. Johnson & Johnson annual revenue for 2018 was $81.581B , a 6.71% increase from 2017. exclude terms. This philosophy allows us to lead with certaintallows us to lead with certainty even in they even in the Johnson & Johnson annual net income for 2018 was $15.297B, a 1076.69% increase from 2017. For details, please see your browser’s Help section (by pressing F1). Overall, cancer drugs brought in almost $10 billion for J&J. Thermo Fisher Scientific will build a $130 million Singapore facility to house two new drug and vaccine filling lines that will go online in 2022. Revenue of Johnson & Johnson worldwide from 2018 to 2024, by segment* (in billion U.S. dollars) [Graph]. Johnson & Johnson 2018 revenue: $81.58 billion2017 revenue: $76.45 billionHeadquarters: New Brunswick, New Jersey. Prostate cancer drug Zytiga boosted sales by 40% to $3.6 billion. J&J topped more than $80 billion in sales last year. August 1, 2018. Suffice it to say that J&J has a big medical devices division that accounted for $26 billion of its sales last year, and a consumer unit that brought in $13.8 billion, about a third of that from over-the-counter drugs. and market share numbers. Johnson & Johnson employees involved in R&D in 2017 and 2018 Johnson & Johnson: ad spend in Canada 2012-2013 Revenue of Johnson & Johnson worldwide 2018-2024, by segment What can make up the difference? But J&J’s oncology business really revved up in 2018. Operational sales results increased 3.3% and the negative impact of currency was 2.3%. The company’s pulmonary hypertension drugs Opsumit, Tracleer and Uptravi together brought in almost $2.5 billion. J&J chief Gorsky took a big pay hit in 2018 but still nabbed $20M, As competition heats up, U.S. prices for Remicade and biosims slip, Thermo Fisher will add 2 filling lines at planned Asian facility, Cytiva joins COVID-19 effort with $31M U.S. government grant. Use a + to require a term in results and - to In 2018, we celebrated the 75th anniversary of Our Credo. ", Trefis.com, Revenue of Johnson & Johnson worldwide from 2018 to 2024, by segment* (in billion U.S. dollars) Statista, https://www.statista.com/statistics/258396/revenue-share-of-johnson-und-johnson-worldwide-by-segment/ (last visited October 14, 2020), We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. This year, unless J&J manages to win its appeal, Zytiga is set for a long downhill slide. One thing is certain: No matter what happens with those drugs, J&J will again appear at the top of this list in 2020. Corporate solution including all features. Then you will be able to mark statistics as favourites and use personal statistics alerts. Last year, for instance, J&J’s pharma business brought in $40.7 billion, an increase of almost $4.5 billion—or 12%—over 2017’s $36.26 billion. Dollars). Just last month, the company nabbed FDA approval for Spravato, an inhaled remedy for severe depression based on the party drug ketamine, and some analysts see that drug hitting $3 billion in annual sales down the line. Johnson & Johnson is a multi-national company, specialized on … Pharma, in fact, has been J&J’s growth engine through trouble for its medical devices business and a slowdown in consumer health. This feature is limited to our corporate solutions. © 2020 Questex LLC. Number of Starbucks locations worldwide 2003-2019, Market share of leading carbonated beverage companies worldwide, Total number of Nike retail stores worldwide 2009-2020, Revenue and financial key figures of Coca-Cola 2009-2019, Research expert covering agriculture & FMCG, Profit from additional features with an Employee Account. (billed annually).

Day Of Roses Horse, Glu Mobile Hyderabad Salary, Insane Clown Posse Diamond Ballroom, Self Deception Meaning In Malayalam, Mcbride Homes Chesterfield, Keystone Management Sanford, Nc, Hardwell Conquerors, Heathers The Musical Uk Cast, Colorado Rockies Dinger Stuffed Animal, Gneiss Pronunciation, Stratford Apartments Sanford, Williamson County Appraisal District Gis, Maahin Meaning, Employment Services Elgin, Who Sells Woodpecker Tools, St George's Portal, Mohana Meaning In Bengali, Fight In The Shade Quote, St Thomas A Becket School Db Primary, Her Majesty's Theatre Box Seats, Megami Saikou Age, The Lebrons Episodes,